2’,3’-Isopropylidene Adenosine-13C5

CAS: 362-75-4

Ref. TR-I824677

Informação sobre produto

• Nome: 2’,3’-Isopropylidene Adenosine-13C5
• Sinónimos: 2',3'-O-(1-Methylethylidene)adenosine-13C5, NSC 29413-13C5, (2xi)-2',3'-O-(1-methylethylidene)adenosine, (3xi)-2',3'-O-(1-methylethylidene)adenosine, 2',3'-Isopropylideneadenosine, 2',3'-O-(1-Methylethylidene)adenosine, 2′,3′-Isopropylideneadenosine, 2′,3′-O-(1-Methylethylidene)adenosine, 2′,3′-O-Isopropylideneadenosine, 9-[2,3-O-(1-methylethylidene)pentofuranosyl]-9H-purin-6-amine, Adenosine, 2',3'-O-(1-methylethylidene)-, Adenosine, 2',3'-O-(l-methylethylidene)-, Adenosine, 2',3'-O-isopropylidene-, Adenosine, 2′,3′-O-(1-methylethylidene)-, Adenosine, 2′,3′-O-isopropylidene-, Ai3-52661, Furo[3,4-d]-1,3-dioxole, adenosine deriv., Nsc 29413

Descrição

Applications 2’,3’-Isopropylidene Adenosine-13C5 is an intermediate in the synthesis of Adenosine 5’-Diphosphate-13C5 Ammonium Salt Hydrate (A281697), which is the isotope labelled analog of Adenosine 5’-Diphosphate Ammonium Salt Hydrate (A281700); a nucleoside diphosphate that interacts with a family of ADP receptors found on platelets (P2Y1, P2Y12 and P2X1), to induce platelet activation. ADP in the blood is converted to adenosine by the action of ecto-ADPases, inhibiting further platelet activation via adenosine receptors.
References Gamba, G. et al.: Haematologia, 58, 1215 (1973); Dejana, E. et al.: Thromb. Haemost., 39, 135 (1978)

• Marca: TRC

Propriedades químicas

• Peso molecular: 312.27
• Fórmula: C₈C₅H₁₇N₅O₄
• Cor/forma: Neat
• InChI: InChI=1S/C13H17N5O4/c1-13(2)21-8-6(3-19)20-12(9(8)22-13)18-5-17-7-10(14)15-4-16-11(7)18/h4-6,8-9,12,19H,3H2,1-2H3,(H2,14,15,16)/t6-,8-,9-,12-/m1/s1/i3+1,6+1,8+1,9+1,12+1
• Chave InChI: InChIKey=NWIMPGMAVYLECN-UHFFFAOYSA-N
• SMILES: COC(=O)Cc1ccc2cc(OC)ccc2c1